Keep up to date on recent Everbridge news, events, and content, including from our recent thought leadership events and articles.
Below are reports* † in which we’ve received recognition. In addition to those published here, we are also excited to be included in:
Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases. Alexion…
Learn how Alexion Pharmaceuticals, Inc.uses Everbridge’s Critical Event Management platform to effectively communicate during all types of incidents.
Incident Communications for Government allows you to send consistent, error-free messages every time to responders and stakeholders and collaborate to ensure processes are followed for repeatable incidents
With Everbridge this high volume PSAP agency saw a 50% reduction in critical message delivery time and was able to…
The Everbridge Unified Critical Communications platform equips healthcare organizations with the solutions needed to deliver high-quality patient care while efficiently keeping staff connected, without violating HIPAA privacy rules.
HipaaBridge is the most secure and easiest to use HIPAA-compliant mobile telemedicine app.
*Forrester reports are available to Forrester subscribers or for purchase.
†Gartner reports are available for Gartner subscribers only
†GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, and HYPE CYCLE is a registered trademark of Gartner, Inc. and/or its affiliates and are used herein with permission. All rights reserved.
†Gartner® does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.